The European Commission and the European Medicines Agency have issued orphan drug designation to PROLOR Biotech's hGH-CTP. The longer-acting version of human growth hormone, hGH-CTP, is being developed to treat growth hormone deficiency. ...
Tags: PROLOR Biotech, hGH-CTP, European Orphan Drug Designation